BAY 3713372 clinical trials

A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors

This study is testing a new drug, BAY 3713372, for certain solid tumours that are missing a specific gene (MTAP-deleted). It aims to find a safe dose, understand how it works in the body, and see if it can shrink these tumours.